Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Immunobiology|August 22, 2006
Feasibility of clinical dendritic cell vaccination in acute myeloid leukemiaIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Immunobiology|September 17, 2005
Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunizationIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Haematologica|March 15, 2006
Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemiaIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Immunobiology|August 22, 2006
Principles of dendritic cell-based immunotherapy in myeloid leukemiaTheresia M Westers, Ilse Houtenbos, Arjan A van de Loosdrecht, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 17, 2005
Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometryTheresia M Westers, Ilse Houtenbos, Gerrit Jan Schuurhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2006
Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targetingIlse Houtenbos, Theresia M Westers, Annemiek Dijkhuis, et al.
European Journal of Clinical Pharmacology|June 12, 2020
Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarolMatthijs L Becker, Renate C A E van Uden, Thijs J Giezen, et al.
Cancer Reports (Hoboken, N.J.)|June 19, 2021
Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapyEvert S M van Aken, Aart Beeker, Ilse Houtenbos, et al.
Cancer Immunology, Immunotherapy : CII|April 12, 2003
Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisationIlse Houtenbos, Theresia M Westers, Anita G M Stam, et al.
Postgraduate Medical Journal|January 14, 2021
Guidelines for mono, double and triple antithrombotic therapyRenate C A E van Uden, Ilse Houtenbos, Anita Griffioen-Keijzer, et al.
Pageof 2